Pharma Deals Review, Vol 2010, No 6 (2010)

Font Size:  Small  Medium  Large

Grifols Buys Talecris to Increase US Share in Plasma Protein Therapies

Debbie Tranter

Abstract


Grifols SA, European major player in blood plasma products acquires Talecris Biotherapeutics for USD 3 B to expand its share in the US market.



Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.